Table 2.
Characteristics of the positive and negative COVID-19 patients.
| Total (N = 1,374) | COVID-19 negative (N = 615) | COVID-19 positive (N = 759) | p-Value | |
|---|---|---|---|---|
| Age, year | 60.40 ± 20.83 | 60.40 ± 20.83 | 62.27 ± 15.84 | 0.066 |
| Female | 583 (42.43%) | 304 (49.43%) | 279 (36.76%) | <0.001 |
| CA, mmol/L | 2.20 ± 0.751 | 2.29 ± 0.74 | 2.14 ± 0.14 | <0.001 |
| CREA, mg/dl | 1.18 ± 1.01 | 1.22 ± 1.20 | 1.14 ± 0.82 | 0.180 |
| ALP, U/L | 87.74 ± 64.26 | 94.18 ± 77.16 | 82.53 ± 50.95 | 0.001 |
| GGT, U/L | 66.12 ± 101.95 | 58.52 ± 118.90 | 72.27 ± 85.40 | 0.013 |
| GLU, mg/dl | 119.03 ± 55.85 | 112.19 ± 49.85 | 124.58 ± 59.73 | <0.001 |
| AST, U/L | 47.11 ± 51.37 | 34.60 ± 33.44 | 57.25 ± 60.37 | <0.001 |
| ALT, U/L | 40.15 ± 40.67 | 32.23 ± 35.22 | 46.56 ± 43.58 | <0.001 |
| LDH, U/L | 336.86 ± 210.61 | 280.76 ± 243.48 | 382.33 ± 166.44 | <0.001 |
| PCR | 72.22 ± 79.59 | 52.86 ± 70.90 | 89.72 ± 82.43 | <0.001 |
| KAL | 4.22 ± 0.51 | 4.25 ± 0.50 | 4.20 ± 0.52 | 0.101 |
| NAT | 138.58 ± 4.66 | 139.10 ± 3.92 | 138.15 ± 5.15 | <0.001 |
| WBC, 109/L | 8.56 ± 4.75 | 9.73 ± 5.45 | 7.62 ± 3.85 | <0.001 |
| RBC, 1012/L | 4.53 ± 0.73 | 4.40 ± 0.75 | 4.64 ± 0.69 | <0.001 |
| HGB, g/dl | 13.18 ± 2.05 | 12.80 ± 2.13 | 13.49 ± 1.94 | <0.001 |
| HCT, % | 39.32 ± 5.64 | 38.32 ± 5.79 | 40.14 ± 5.39 | <0.001 |
| MCV, fl | 87.33 ± 6.93 | 87.76 ± 7.23 | 86.97 ± 6.65 | <0.001 |
| MCH, pg/cell | 29.25 ± 2.69 | 29.27 ± 2.76 | 29.23 ± 2.63 | 0.783 |
| MCHC, g Hb/dl | 33.48 ± 1.34 | 33.34 ± 1.35 | 33.60 ± 1.32 | <0.001 |
| PLT1, 109/L | 234.74 ± 95.89 | 246.55 ± 98.70 | 225.17 ± 92.51 | <0.001 |
| NE, % | 72.35 ± 13.26 | 70.33 ± 13.47 | 73.98 ± 12.86 | <0.001 |
| LY, % | 18.58 ± 11.00 | 19.73 ± 11.37 | 17.65 ± 10.62 | 0.001 |
| MO, % | 7.83 ± 3.88 | 8.06 ± 3.61 | 7.65 ± 4.08 | 0.045 |
| EO, % | 0.88 ± 1.62 | 1.43 ± 2.02 | 0.44 ± 1.00 | <0.001 |
| BA, % | 0.34 ± 0.327 | 0.43 ± 0.31 | 0.26 ± 0.21 | <0.001 |
| NET, 109/L | 6.45 ± 4.48 | 7.15 ± 5.28 | 5.88 ± 3.60 | <0.001 |
| LYT, 109/L | 1.37 ± 0.95 | 1.64 ± 1.02 | 1.15 ± 0.83 | <0.001 |
| MOT, 109/L | 0.62 ± 0.54 | 0.72 ± 0.45 | 0.54 ± 0.59 | <0.001 |
| EOT, 109/L | 0.07 ± 0.14 | 0.12 ± 0.18 | 0.03 ± 0.08 | <0.001 |
| BAT, 109/L | 0.02 ± 0.04 | 0.03 ± 0.05 | 0.01 ± 0.02 | <0.001 |
| Suspect, % | 0.83 ± 0.33 | 0.71 ± 0.39 | 0.92 ± 0.23 | <0.001 |
CA, calcium; CREA, creatinine; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase, an enzyme that converts glutamyl to glutamine; GLU, glucose; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase, a type of enzyme that breaks down lactate; WBC, white blood cell; RBC, red blood cell; HGB, hemoglobin, a protein that transports oxygen throughout the body; HCT, hematocrit, a metric representing the proportion of RBCs in the blood; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT1, platelets; NE, neutrophil count (%); LY, lymphocyte count (%); MO, monocyte count (%); EO, eosinophil count (%);BA, basophil count (%); NET, neutrophil count; LYT, lymphocyte count; MOT, monocyte count; EOT, eosinophil count; BAT, basophil count; Suspect, suspected COVID-19.